<!DOCTYPE html>
<html>

<head>
	<title>Dyspnea Evaluation</title>
	<meta charset='UTF-8' />
	<meta name="viewport" content="width=device-width, user-scalable=yes">
	<link rel="stylesheet" type="text/css" href="../utility/bootstrap/css/bootstrap.css">
	<link rel="stylesheet" type="text/css" href="../utility/style.css">
	<link rel="stylesheet" type="text/css" href="style.css">
	<script type="text/javascript" src="../utility/utility.js"></script>
</head>

<body class = "dyspne-body">

	<div class = "container-fluid">
		<div class = "row">
		<!-- Padding left -->
		<div class = "col-lg-2 col-md-1 col-sm-0"></div>

		<!-- Main Content -->
		<div class = "col-lg-8 col-md-10 col-sm-12">
			<!-- Image -->
			<div class="row image-box">
				<object data="img/dyspne-algorithm-eng.jpg" class="image-jpg" width="100%" height="70%"></object>
			</div>
			<!-- End of Image -->

			<!-- Evaluation steps -->
			<div class = "container-fluid">
			<div class = "row">
				<div class = "col-md-4 col-sm-12">
					<h4>
						Step 1 - Basic evaluation
					</h4>
					<p>
						The basic investigation should include, in addition to the assessment of vital signs,
						a thorough medical history and careful clinical examination. A broad differential
						diagnosis is required to identify or rule out the most common causes of dyspnea.
						About two-thirds  of cases of chronic dyspnea are caused by heart or lung diseases.
					</p>
				</div>
				<div class = "col-md-4 col-sm-12">
					<h4>
						Step 2 - Targeted evaluation
					</h4>
					<p>
						Based on the overall clinical question and the findings from Step 1,
						targeted examinations are performed. If a diagnosis cannot be established after
						investigations according to Steps 1 and 2, early contact should be made with a specialist center.
					</p>
				</div>
				<div class = "col-md-4 col-sm-12">
					<h4>
						Step 3 - Specialist center for PH
					</h4>
					<p>
						At this stage, the patient undergoes further evaluation to diagnose and treat PAH and CTEPH. 
						All follow-up and medication adjustments are managed through the specialist center.
					</p>
				</div>
			</div>
			</div>
			 <!-- End of Evaluation steps -->

			<!-- Additional information -->
			<button class="collapsible" onclick="collapseContent(this)">Click to show Additional Information</button>
			<div id="ref" class="collapsible-content">
				<div class = "container-fluid">
				<div class="row additional-info">
					<div class = "col-md-4 col-sm-12">
						* Disease specific biomarkers, including sweat testing for cystic fibrosis, 
						genetic testing, tissue biopsies, and the potential use of emerging and validated cardiopulmonary biomarkers of dyspnea.
						<br>
						** Fast-track referral as suggested by the 2022 ESC/ERS PH 
						guidelines algorithm in case of high suspicion/likelihood of PAH or CTEPH.
					</div>
					<div class = "col-md-4 col-sm-12">
						<sup>a</sup> In cases of suspected PAH/CTEPH or unclear etiology after Steps 1 and 2.
						<br>
						<sup>b</sup>CPET is not performed routinely but can provide complementary  information to the 6-minute walk test.
					</div>
					<div class = "col-md-4 col-sm-12">
						<sup>c</sup>Shunt evaluation - stepwise measurement of O2 saturation.
						<br>
						<sup>d</sup> Performed in the presence of signs of precapillary pulmonary hypertension after 
						right heart catheterization, as well as imaging findings indicating chronic pulmonary embolism.
					</div>
				</div>
				</div>
			</div>
			<!-- End of Additional information -->
				
			<!-- References -->
			<button class="collapsible" onclick="collapseContent(this)">Click to show References</button>
			<div id="ref" class="collapsible-content">
				<ol>
					<li>
						<!-- Authors -->
						Ahmed S., Ahmed A., Rådegran G.
						<!-- Title -->
						Structured evaluation of unclear dyspnea - 
						of great importance to early identify patients with PAH and CTEPH and improve prognosis.
						<!-- Journal  -->
						<i>Läkartidningen</i>. 2022;119:21238.
					</li>

					<li>
						<!-- Authors -->
						Ahmed S., Ahmed A., Rådegran G.
						<!-- Title -->
						Structured evaluation of unclear dyspnea - 
						An attempt to shorten the diagnostic delay in pulmonary arterial hypertension and chronic thromboembolic pulmonary  hypertension.
						<!-- Journal  -->
						<i>Pulm Circ</i>. 2024;14:e12340.
					</li>

					<li>
						<!-- Authors -->
						Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J,
						Coats AJS, Escribano-Subias P, Ferrari P, Ferreira DS, Ghofrani HA, Giannakoulas G,
						Kiely DG, Mayer E, Meszaros G, Nagavci B, Olsson  KM, Pepke-Zaba J, Quint JK, Rådegran G,
						Simonneau G, Sitbon O, Tonia T, Toshner M, Vachiery JL, Vonk Noordegraaf A, Delcroix M, Rosenkranz S, Group EESD.
						<!-- Title -->
						2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: 
						Developed by the task  force for the diagnosis and treatment of pulmonary hypertension 
						of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). 
						Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the 
						European Reference Network on rare respiratory diseases (ERN-LUNG).
						<!-- Journal  -->
						<i>European Heart Journal</i>. 2022;43(38):3618-3731.
					</li>
				</ol>
			</div>
			<!-- End of references -->

		</div>
		<!-- End of main content -->
		
		<!-- Padding right -->
		<div class = "col-lg-2 col-md-1 col-sm-0"></div>
	</div>
	</div>

	<!-- Footer -->
	<footer class="page-footer footer-title" style="min-height: 5em;">
		<div class="footer-copyright text-center">
			<p><b>Developed by:</b> Salaheldin Ahmed<sup>1,2</sup>, Abdulla Ahmed<sup>1,2</sup>, Daniel Kempe<sup>1</sup> and
				Göran Rådegran<sup>1,2</sup></p>
			<p><b>Contact information:</b> salaheldin.ahmed@med.lu.se; goran.radegran@med.lu.se</p>
			<p><sup>1</sup>The Department of Clinical Sciences Lund, The Section for Cardiology, Lund University, Lund,
				Sweden,</p>
			<p><sup>2</sup>The Haemodyniamic Lab, The Section for Heart Failure and Valvular Disease, Heart and Lung Medicin,
				Skåne University Hospital, Lund, Sweden</p>
		</div>
	</footer>
</body>